La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage

Identifieur interne : 002F32 ( Main/Exploration ); précédent : 002F31; suivant : 002F33

Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage

Auteurs : Adam O. Hebb [Canada] ; Kari Hebb ; Arun C. Ramachandran ; Ivar Mendez

Source :

RBID : Pascal:03-0290132

Descripteurs français

English descriptors

Abstract

Object. Transplantation of fetal dopaminergic tissue is being investigated in animal models and clinical trials for its potential as a treatment for advanced Parkinson disease. At the same time the availability of fetal tissue is limited, making its storage time prior to transplantation a key practical issue. Although it results in a smaller percentage of surviving cells. a longer storage time enables fetal tissue obtained over several days to be pooled for transplantation in a recipient. Glial cell line-derived neurotrophic factor (GDNF) has been shown to improve survival of human dopaminergic tissue that has been stored prior to transplantation. The objective of this study was to evaluate the effects on fetal dopaminergic tissue of GDNF-supplemented hibernation for extended periods of 6 to 15 days. Methods. The ventral mesencephalon (VM) was harvested in a total of 27 14-day-old rat fetuses, and three VMs were cultured immediately (fresh control group). The remaining 24 VMs were divided sagittally along the midline to yield 48 equal pieces of hemimesencephalon. Twenty-four pieces were stored with GDNF-supplemented hibernation medium for 6, 9. 12, or 15 days, and the 24 "partner" hemimesencephalon pieces were stored in control hibernation medium for the same periods of time. Tissue was cultured for 48 hours and processed for tyrosine hydroxylase (TH) immunoreactivity and double-stained with cresyl violet. Cell counts for all cultures and the percentage of TH-immunoreactive cells were obtained. The percentage of TH-immunoreactive cells for the fresh control group was 6.3 ± (0.5%. The percentage of TH-immunoreactive cells in cultures derived from tissue stored in GDNF-supplemented medium was significantly increased at 6 and 9 days posthibernation compared with the fresh control group and the "partner" groups stored in hibernation medium only. No significant increase in the percentage of TH-immunoreactive cells was observed in the 12- and 15-day group;. Conclusions. In this study the authors have demonstrated that fetal dopaminergic tissue can be safely stored for up to 9 days in GDNF-supplemented hibernation medium. Furthermore, the percentage of TH-immunoreactive cells is significantly increased after 6 and 9 days of storage in this medium, improving the yield of TH-immunoreactive cells prior to transplantation. These observations have practical clinical implications for collecting fetal dopaminergic cells and improving their survival after transplantation.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage</title>
<author>
<name sortKey="Hebb, Adam O" sort="Hebb, Adam O" uniqKey="Hebb A" first="Adam O." last="Hebb">Adam O. Hebb</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Departments of Anatomy, Neurobiology, and Surgery (Division of Neurosurgery), Faculty of Medicine, Dalhousie University</s1>
<s2>Halifax, Nova Scotia</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Halifax, Nova Scotia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hebb, Kari" sort="Hebb, Kari" uniqKey="Hebb K" first="Kari" last="Hebb">Kari Hebb</name>
</author>
<author>
<name sortKey="Ramachandran, Arun C" sort="Ramachandran, Arun C" uniqKey="Ramachandran A" first="Arun C." last="Ramachandran">Arun C. Ramachandran</name>
</author>
<author>
<name sortKey="Mendez, Ivar" sort="Mendez, Ivar" uniqKey="Mendez I" first="Ivar" last="Mendez">Ivar Mendez</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0290132</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0290132 INIST</idno>
<idno type="RBID">Pascal:03-0290132</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A70</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000253</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000951</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000951</idno>
<idno type="wicri:doubleKey">0022-3085:2003:Hebb A:glial:cell:line</idno>
<idno type="wicri:Area/Main/Merge">003337</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12744369</idno>
<idno type="wicri:Area/PubMed/Corpus">001438</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001438</idno>
<idno type="wicri:Area/PubMed/Curation">001438</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001438</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001438</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001438</idno>
<idno type="wicri:Area/Ncbi/Merge">000304</idno>
<idno type="wicri:Area/Ncbi/Curation">000304</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000304</idno>
<idno type="wicri:doubleKey">0022-3085:2003:Hebb A:glial:cell:line</idno>
<idno type="wicri:Area/Main/Merge">003168</idno>
<idno type="wicri:Area/Main/Curation">002F32</idno>
<idno type="wicri:Area/Main/Exploration">002F32</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage</title>
<author>
<name sortKey="Hebb, Adam O" sort="Hebb, Adam O" uniqKey="Hebb A" first="Adam O." last="Hebb">Adam O. Hebb</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Departments of Anatomy, Neurobiology, and Surgery (Division of Neurosurgery), Faculty of Medicine, Dalhousie University</s1>
<s2>Halifax, Nova Scotia</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Halifax, Nova Scotia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hebb, Kari" sort="Hebb, Kari" uniqKey="Hebb K" first="Kari" last="Hebb">Kari Hebb</name>
</author>
<author>
<name sortKey="Ramachandran, Arun C" sort="Ramachandran, Arun C" uniqKey="Ramachandran A" first="Arun C." last="Ramachandran">Arun C. Ramachandran</name>
</author>
<author>
<name sortKey="Mendez, Ivar" sort="Mendez, Ivar" uniqKey="Mendez I" first="Ivar" last="Mendez">Ivar Mendez</name>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of neurosurgery</title>
<title level="j" type="abbreviated">J. neurosurg.</title>
<idno type="ISSN">0022-3085</idno>
<imprint>
<date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of neurosurgery</title>
<title level="j" type="abbreviated">J. neurosurg.</title>
<idno type="ISSN">0022-3085</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Animals</term>
<term>Brain Tissue Transplantation</term>
<term>Cell Line</term>
<term>Cell Survival (drug effects)</term>
<term>Cell culture</term>
<term>Child</term>
<term>Culture Media</term>
<term>Dopamine (metabolism)</term>
<term>Dopaminergic neuron</term>
<term>Experimental study</term>
<term>Fetal Tissue Transplantation</term>
<term>Glial Cell Line-Derived Neurotrophic Factor</term>
<term>Glial cell line derived neurotrophic factor</term>
<term>Hibernation</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>Long term</term>
<term>Midbrain</term>
<term>Nerve Growth Factors (pharmacology)</term>
<term>Neuroprotective Agents (pharmacology)</term>
<term>Parkinson Disease (surgery)</term>
<term>Parkinson disease</term>
<term>Rats</term>
<term>Storage</term>
<term>Tissue Preservation (methods)</term>
<term>Transplantation</term>
<term>Treatment</term>
<term>Tyrosine 3-Monooxygenase (metabolism)</term>
<term>Ventral Tegmental Area (transplantation)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Dopamine</term>
<term>Tyrosine 3-Monooxygenase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Nerve Growth Factors</term>
<term>Neuroprotective Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Culture Media</term>
<term>Glial Cell Line-Derived Neurotrophic Factor</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Survival</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Tissue Preservation</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="transplantation" xml:lang="en">
<term>Ventral Tegmental Area</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Brain Tissue Transplantation</term>
<term>Cell Line</term>
<term>Fetal Tissue Transplantation</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>Rats</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Facteur GDNF</term>
<term>Transplantation</term>
<term>Hibernation</term>
<term>Stockage</term>
<term>Long terme</term>
<term>Culture cellulaire</term>
<term>Traitement</term>
<term>Animal</term>
<term>Enfant</term>
<term>Etude expérimentale</term>
<term>Neurone dopaminergique</term>
<term>Mésencéphale</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Stockage</term>
<term>Enfant</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Object. Transplantation of fetal dopaminergic tissue is being investigated in animal models and clinical trials for its potential as a treatment for advanced Parkinson disease. At the same time the availability of fetal tissue is limited, making its storage time prior to transplantation a key practical issue. Although it results in a smaller percentage of surviving cells. a longer storage time enables fetal tissue obtained over several days to be pooled for transplantation in a recipient. Glial cell line-derived neurotrophic factor (GDNF) has been shown to improve survival of human dopaminergic tissue that has been stored prior to transplantation. The objective of this study was to evaluate the effects on fetal dopaminergic tissue of GDNF-supplemented hibernation for extended periods of 6 to 15 days. Methods. The ventral mesencephalon (VM) was harvested in a total of 27 14-day-old rat fetuses, and three VMs were cultured immediately (fresh control group). The remaining 24 VMs were divided sagittally along the midline to yield 48 equal pieces of hemimesencephalon. Twenty-four pieces were stored with GDNF-supplemented hibernation medium for 6, 9. 12, or 15 days, and the 24 "partner" hemimesencephalon pieces were stored in control hibernation medium for the same periods of time. Tissue was cultured for 48 hours and processed for tyrosine hydroxylase (TH) immunoreactivity and double-stained with cresyl violet. Cell counts for all cultures and the percentage of TH-immunoreactive cells were obtained. The percentage of TH-immunoreactive cells for the fresh control group was 6.3 ± (0.5%. The percentage of TH-immunoreactive cells in cultures derived from tissue stored in GDNF-supplemented medium was significantly increased at 6 and 9 days posthibernation compared with the fresh control group and the "partner" groups stored in hibernation medium only. No significant increase in the percentage of TH-immunoreactive cells was observed in the 12- and 15-day group;. Conclusions. In this study the authors have demonstrated that fetal dopaminergic tissue can be safely stored for up to 9 days in GDNF-supplemented hibernation medium. Furthermore, the percentage of TH-immunoreactive cells is significantly increased after 6 and 9 days of storage in this medium, improving the yield of TH-immunoreactive cells prior to transplantation. These observations have practical clinical implications for collecting fetal dopaminergic cells and improving their survival after transplantation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Hebb, Kari" sort="Hebb, Kari" uniqKey="Hebb K" first="Kari" last="Hebb">Kari Hebb</name>
<name sortKey="Mendez, Ivar" sort="Mendez, Ivar" uniqKey="Mendez I" first="Ivar" last="Mendez">Ivar Mendez</name>
<name sortKey="Ramachandran, Arun C" sort="Ramachandran, Arun C" uniqKey="Ramachandran A" first="Arun C." last="Ramachandran">Arun C. Ramachandran</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Hebb, Adam O" sort="Hebb, Adam O" uniqKey="Hebb A" first="Adam O." last="Hebb">Adam O. Hebb</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F32 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F32 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:03-0290132
   |texte=   Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022